Kekkan Biologics
PrivateLast Round
Grant
Jul 5, 2023
Total Funding Raised
$670,000
Company Overview
Kekkan Biologics operates in Healthcare & Life Sciences and is based in Strasbourg. Its latest recorded funding round was a Grant round in July 2023.
Kekkan Biologics is a biotechnology company that develops first-in-class bispecific antibodies targeting lymphatic and vascular angiogenesis to treat metastatic cancers and fibrotic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kekkan Biologics Comparables
Compare Kekkan Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Massalia Therapeutics | 73% | |
| SPIMA Therapeutics | 70% | |
| PharmAbcine Inc. | 66% |
For institutional investors. Book with your work email.
Kekkan Biologics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Kekkan Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Landmark BioVentures AG | Accelerator |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 5, 2023
$670K grant received from Bpifrance.
For institutional investors. Book with your work email.
Kekkan Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kekkan Biologics's valuation, stock price, and market status.
Is Kekkan Biologics a public or private company?
Kekkan Biologics is a private company.
What is the current stock price of Kekkan Biologics?
Kekkan Biologics is a private company, so its shares have no public market price. Caplight tracks Kekkan Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kekkan Biologics worth (valuation)?
Valuation information for Kekkan Biologics is not publicly available.
Can I buy Kekkan Biologics stock?
Kekkan Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kekkan Biologics's last funding round?
Kekkan Biologics's most recent funding round was Grant on July 5, 2023.
Who are the main investors in Kekkan Biologics?
Key investors in Kekkan Biologics include Landmark BioVentures AG.
Will Kekkan Biologics IPO soon?
No public IPO plans have been announced for Kekkan Biologics.
How can I track Kekkan Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Kekkan Biologics's shares on secondary markets.